Sarah Cannon Research Institute is a clinical research site located in Chattanooga, Tennessee, United States 37404.
Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Institute has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative.
Sponsors: Dana-Farber Cancer Institute, Astellas Pharma Global Development, Inc., Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Chattanooga
Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Institute has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Institute has 5 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative.
Sarah Cannon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.